The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma

INTRODUCTION: For patients with diffuse large B‐cell lymphoma (DLBCL), standard‐care is rituximab administered with CHOP or CHOP‐like chemotherapy (R‐CHOP). However, the effectiveness and safety of R‐CHOP among DLBCL patients with human immunodeficiency virus (HIV) infection is less clear, as HIV+ p...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Med
Huvudupphovsmän: Habbous, Steven, Guo, Helen, Beca, Jaclyn, Dai, Wei Fang, Isaranuwatchai, Wanrudee, Cheung, Matthew, Chan, Kelvin K. W.
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2020
Ämnen:
Clinical Cancer Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541135/
https://ncbi.nlm.nih.gov/pubmed/32794362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3362
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk